Design and evaluation of polymeric ocular drug delivery system

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 9, 2009, Pages 914-919

  Gorle, Ashish Prakash ^a   Gattani, Suredra Ganeshlal ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Conjunctivitis; Gatifloxacin; In vitro in vivo release; Ocular insert; Stability study

Indexed keywords

BENZALKONIUM CHLORIDE; BUFFER; CHITOSAN; GATIFLOXACIN; GELLAN; MACROGOL 400; PLASTICIZER; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARTMENT MODEL; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; DRUG STABILITY; FILM; MALE; MEAN RESIDENCE TIME; MOISTURE; NONHUMAN; OCULAR INSERT; RABBIT; THICKNESS; WEIGHT;

ANIMALS; ANTI-INFECTIVE AGENTS; CONJUNCTIVITIS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STABILITY; FLUOROQUINOLONES; KINETICS; PLASTICIZERS; POLYMERS; RABBITS;

EID: 70349167076     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.914     Document Type: Article

References (23)

1. Venkateshwar R., Somashekar S., Turk. J. Med. Sci., 34, 239-246 (2004).
2. Zimmer A., Kreuter J., Adv. Drug Deliv. Rev., 16, 61-73 (1995).
3. Kaur I. P., Kanwar M., Drug Dev. Ind. Pharm., 28, 473-493 (2002).
4. Sreenivas S. A., Hiremath S. P., Godbole A. M., Iran. J. Pharmacol. Therap., 5, 159-162 (2006).
5. Kaur I. P., Smitha R., Drug Dev. Ind. Pharm., 28, 353-369 (2002).
6. Robinson J. R., Worakul N., Eur. J. Pharm. Biopharm., 44, 71-83 (1997).
7. Zaki I., Fitzgerald P., Hardy J. G., Wilson C. G., J. Pharm. Pharmacol., 38, 463-466 (1986).
8. Chrai S. S., Makoid M. C., Erikson S., Robinson J. R., J. Pharm. Sci., 63, 333-338 (1974).
9. Hwang D. G., Surv. Ophthalmol., 49, S79-S83 (2004).
10. Felt O., Furrer P., Mayer J. M., Plazonnet B., Buri P., Gurny R., Int. J. Pharm., 180, 185-193 (1999).
11. Colo D. G., Zambito Y., Burgalassi S., Serafini A., Saettone M. F., Int. J. Pharm., 248, 115-122 (2002).
12. Balasubramanium J., Kant S., Pandit J. K., Acta Pharm., 53, 251-261 (2003).
13. Nafee N. A., Ismail F. A., Acta Pharm., 53, 199-212 (2003).
14. Sultana Y., Aqil M., Ali A., Acta Pharm., 55, 305-314 (2005).
15. Patel U., Chaudhary K. A., Chotai N. P., Chirag N., Patel K. N., Indian J. Pharm. Educ. Res., 42, 262-267 (2008).
16. Mundada A. S., Shrikhande B. K., Drug Dev. Ind. Pharm., 32, 443-448 (2006).
17. Dandagi P. M., Manvi F. V., Patil M. B., Mastiholimath V. S., Rathod R., Indian J. Pharm. Sci., 66, 309-312 (2004).
18. Graber H., The Eastern Pharmacists, 7, 25-30 (1991).
19. Saisivam S., Manikandav R. V., Nagarajan M., Indian J. Pharm. Sci., 61, 34-38 (1999).
20. Jayaprakash S., James C. C., Maria G. R., Saisivam S. S., Nagrajan M., Indian J. Pharm. Sci., 62, 334-338 (2000).
21. Aquil M., www.pharmainfo.net 1-14 (2005).
22. Kaur I. P., Singh M., Kanwas M., Int. J. Pharm., 199, 119-127 (2000).
23. Charoo N. A., Kohli K., Ali A., Anwer A., Drug Dev. Ind. Pharm., 29, 215-221 (2003).